About 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide
2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide (PubChem CID 146853136) has the molecular formula C31H35FN6O4
and a molecular weight of 574.66 g/mol. Its IUPAC name is 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide.
Molecular Properties
| Compound Name | 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide |
| PubChem CID | 146853136 |
| Molecular Formula | C31H35FN6O4 |
| Molecular Weight | 574.66 g/mol |
| Exact Mass | 574.27 |
| IUPAC Name | 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide |
| SMILES | O=C(CCCCN1CCCC1=O)c1ccc(N2CCN(c3ccc(F)nc3)CC2)c(NC(=O)c2coc(C3CC3)n2)c1 |
| InChI | InChI=1S/C31H35FN6O4/c32-28-11-9-23(19-33-28)36-14-16-37(17-15-36)26-10-8-22(27(39)4-1-2-12-38-13-3-5-29(38)40)18-24(26)34-30(41)25-20-42-31(35-25)21-6-7-21/h8-11,18-21H,1-7,12-17H2,(H,34,41) |
| InChIKey | SJBGKBZUXATTJM-UHFFFAOYSA-N |
| XLogP | 4.64 |
| TPSA | 111.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 574.66 |
| LogP ≤ 5 | 4.64 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide?
The IUPAC name of 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide (CID 146853136) is 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide.
What is the SMILES notation for 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide?
The canonical SMILES for 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide is O=C(CCCCN1CCCC1=O)c1ccc(N2CCN(c3ccc(F)nc3)CC2)c(NC(=O)c2coc(C3CC3)n2)c1.
What is the InChIKey of 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide?
The InChIKey is SJBGKBZUXATTJM-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H35FN6O4/c32-28-11-9-23(19-33-28)36-14-16-37(17-15-36)26-10-8-22(27(39)4-1-2-12-38-13-3-5-29(38)40)18-24(26)34-30(41)25-20-42-31(35-25)21-6-7-21/h8-11,18-21H,1-7,12-17H2,(H,34,41).
What are the key properties of 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide?
2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide has a molecular weight of 574.66 g/mol, XLogP of 4.64, 11 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-N-[2-[4-(6-fluoro-3-pyridinyl)piperazin-1-yl]-5-[5-(2-oxopyrrolidin-1-yl)pentanoyl]phenyl]-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 146853136), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).